Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LEMLEY, K. V.
Right arrow Articles by NELSON, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LEMLEY, K. V.
Right arrow Articles by NELSON, R. G.
J Am Soc Nephrol 11:2095-2105, 2000
© 2000 American Society of Nephrology

Glomerular Permselectivity at the Onset of Nephropathy in Type 2 Diabetes Mellitus

KEVIN V. LEMLEY*,{dagger}, KRISTINA BLOUCH{dagger}, ISHA ABDULLAH{dagger}, DEREK B. BOOTHROYD{ddagger}, PETER H. BENNETT§, BRYAN D. MYERS{dagger} and ROBERT G. NELSON§

* Division of Pediatric Nephrology, Stanford University School of Medicine, Stanford, California
{dagger} Division of Nephrology, Stanford University School of Medicine, Stanford, California
{ddagger} Department of Statistics, Stanford University School of Medicine, Stanford, California
§ Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes, Digestive and Kidney Diseases, Phoenix, Arizona.

Correspondence to Dr. Kevin V. Lemley, Division of Pediatric Nephrology, Room G306, Stanford University Medical Center, Stanford, CA 94305-5208. Phone: 650-723-7903; Fax: 650-498-6714; E-mail: klemley{at}leland.stanford.edu

Abstract. The development of microalbuminuria in individuals with type 2 diabetes mellitus is associated with a 10-fold increase in the risk of progression to overt nephropathy and eventual end-stage renal failure. The present study reports long-term (up to 8 yr) follow-up of 43 Pima Indians with type 2 diabetes detected on screening to have microalbuminuria. The natural history of albuminuria in these individuals included progression to overt proteinuria (urinary albumin excretion >= 300 mg/d) in half of the participants by 7 yr of follow-up. The size selectivity of the glomerular barrier was also investigated using dextran sieving and pore theory. Whereas a comparison group of macroalbuminuric Pima Indians had an excess of large pores that served as a macromolecular "shunt," individuals with microalbuminuria had a shunt size no different from long-term diabetic, normoalbuminuric control subjects. An abrupt transition from little or no relationship to a highly significant and positive relationship between increasing albuminuria and shunt size occurred at an albumin-to-creatinine ratio of approximately 3000 mg/g. Shunt size in macroalbuminuric individuals correlated with the extent of foot process broadening. Podocyte foot processes in microalbuminuric participants were not different from those in control subjects. In conclusion, although microalbuminuria in type 2 diabetic Pima Indians often heralds progressive glomerular injury, it is not the result of defects in the size permselectivity of the glomerular barrier but rather of changes in either glomerular charge selectivity or tubular handling of filtered proteins or of a combination of these two factors.




This article has been cited by other articles:


Home page
 J. Histochem. Cytochem.Home page
O. Kwon, S.-M. Hong, and K. Blouch
Alteration in Renal Organic Anion Transporter 1 After Ischemia/Reperfusion in Cadaveric Renal Allografts
J. Histochem. Cytochem., June 1, 2007; 55(6): 575 - 584.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Rincon-Choles, T. L. Vasylyeva, P. E. Pergola, B. Bhandari, K. Bhandari, J.-H. Zhang, W. Wang, Y. Gorin, J. L. Barnes, and H. E. Abboud
ZO-1 Expression and Phosphorylation in Diabetic Nephropathy.
Diabetes, April 1, 2006; 55(4): 894 - 900.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
K. V. Lemley, D. B. Boothroyd, K. L. Blouch, R. G. Nelson, L. I. Jones, R. A. Olshen, and B. D. Myers
Modeling GFR trajectories in diabetic nephropathy
Am J Physiol Renal Physiol, October 1, 2005; 289(4): F863 - F870.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Chagnac, T. Weinstein, M. Herman, J. Hirsh, U. Gafter, and Y. Ori
The Effects of Weight Loss on Renal Function in Patients with Severe Obesity
J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1480 - 1486.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Doublier, G. Salvidio, E. Lupia, V. Ruotsalainen, D. Verzola, G. Deferrari, and G. Camussi
Nephrin Expression Is Reduced in Human Diabetic Nephropathy: Evidence for a Distinct Role for Glycated Albumin and Angiotensin II
Diabetes, April 1, 2003; 52(4): 1023 - 1030.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
H. Pavenstadt, W. Kriz, and M. Kretzler
Cell Biology of the Glomerular Podocyte
Physiol Rev, January 1, 2003; 83(1): 253 - 307.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673